Investment Thesis: We focus on platform technologies with broad applicability and therapeutics with strong risk-benefit profiles. We place a particular emphasis on neurodevelopmental disorders and traumatic brain injury.
Direct Investment Portfolio
-
BrainSpace Medical
Protecting the brain after injury, stroke or surgery, starts with managing pressure and draining cerebrospinal fluid (CSF).
-
Veda Bio
VedaBio is unlocking a universe of possibilities in molecular biology with a breakthrough platform for near-instant molecular detection of highly multiplexed analytes, delivering best-in-class accuracy without the need for target amplification.
-
Wave Neuroscience
TMS-based neuromodulation technology backed by fourteen third-party clinical studies led by world-renowned research institutions.
-
WetWare BioSystems
DoD-funded medical technology start-up working at the cutting edge of traumatic brain injury treatment.
-
Pitch Us!
Please submit an intro and your ideas! We are looking at psychedelics, medical devices, and digital innovations for brain health.
Fund Investment Portfolio
-
![]()
Tabula Rasa Ventures
Fund and high-touch accelerator for disruptive technologies in psychedelics and adjacent market verticals: digital, clinical, and manufacturing.
-
![]()
Iaso Ventures
Catalyzing Biodigital Innovation for Next-Gen Life Sciences
-
![]()
Palo Santo
Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world.
-
![]()
Noetic Fund
Fund investing in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe, with an emphasis on psychedelic verticals.
-
![]()
Pitch Us!
Please submit an intro and your ideas! We are looking at psychedelics, medical devices, and digital innovations for brain health.
Hector Ventures is an Yde family enterprise investing in pharmaceutical and medtech value chains. We take a technology-first approach to targeting disruptive health & research platforms (e.g. combinatorial therapeutics, digital health programs, and psychoactive NCEs). In these spaces, we focus primarily on neuropsychiatric therapeutics and neurodevelopmental augmentation (especially autism).
Our name, “Hector Ventures”, takes inspiration from our home-base in Hector, New York.